IL132677A0 - Compounds - Google Patents

Compounds

Info

Publication number
IL132677A0
IL132677A0 IL13267798A IL13267798A IL132677A0 IL 132677 A0 IL132677 A0 IL 132677A0 IL 13267798 A IL13267798 A IL 13267798A IL 13267798 A IL13267798 A IL 13267798A IL 132677 A0 IL132677 A0 IL 132677A0
Authority
IL
Israel
Prior art keywords
compounds
Prior art date
Application number
IL13267798A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL132677A0 publication Critical patent/IL132677A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13267798A 1997-05-05 1998-04-28 Compounds IL132677A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9701682A SE9701682D0 (sv) 1997-05-05 1997-05-05 Compounds
PCT/SE1998/000792 WO1998050380A1 (fr) 1997-05-05 1998-04-28 Composes

Publications (1)

Publication Number Publication Date
IL132677A0 true IL132677A0 (en) 2001-03-19

Family

ID=20406836

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13267798A IL132677A0 (en) 1997-05-05 1998-04-28 Compounds

Country Status (28)

Country Link
US (1) US6166030A (fr)
EP (1) EP0983266B1 (fr)
JP (1) JP2001523263A (fr)
KR (1) KR20010012227A (fr)
CN (1) CN1255130A (fr)
AR (1) AR012602A1 (fr)
AT (1) ATE210661T1 (fr)
AU (1) AU734394B2 (fr)
BR (1) BR9808725A (fr)
CA (1) CA2287999A1 (fr)
DE (1) DE69802923T2 (fr)
DK (1) DK0983266T3 (fr)
EE (1) EE9900475A (fr)
ES (1) ES2168757T3 (fr)
HU (1) HUP0003766A3 (fr)
ID (1) ID23156A (fr)
IL (1) IL132677A0 (fr)
IS (1) IS5237A (fr)
MX (1) MXPA99009874A (fr)
NO (1) NO995404L (fr)
NZ (1) NZ500676A (fr)
PL (1) PL336854A1 (fr)
PT (1) PT983266E (fr)
SE (1) SE9701682D0 (fr)
SK (1) SK140699A3 (fr)
TR (1) TR199902719T2 (fr)
WO (1) WO1998050380A1 (fr)
ZA (1) ZA983740B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001024826A2 (fr) * 1999-10-06 2001-04-12 The Brigham And Women's Hospital, Inc. Composes et procedes de modulation des effets non transcriptionnels des hormones steroides
US6683108B1 (en) * 2000-03-30 2004-01-27 Curis, Inc. Agonists of hedgehog signaling pathways and uses related thereto
US7115653B2 (en) * 2000-03-30 2006-10-03 Curis, Inc. Small organic molecule regulators of cell proliferation
US8852937B2 (en) * 2000-03-30 2014-10-07 Curis, Inc. Small organic molecule regulators of cell proliferation
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
PT1883451E (pt) 2005-04-13 2011-03-02 Neuraxon Inc Compostos de indolo substituídos com actividade inibitória da sintetase de óxido nítrico (nos)
CL2008000838A1 (es) * 2007-03-23 2008-10-10 Neuraxon Inc Compuestos derivados de quinolina y tetrahidroquinolina, con actividad inhibidora nos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un dolor de cabeza tal como migrana, dolor cronico, desordenes del sistema nervios
WO2009062319A1 (fr) 2007-11-16 2009-05-22 Neuraxon, Inc. Composés d'indole et procédés de traitement de la douleur viscérale

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9407515A (pt) * 1993-08-12 1997-01-07 Astra Ab Composto formulação farmaceutica uso do composto processos para o tratamento de desordens neurodegenerativas ou de enxaqueca ou para a prevenção e a reversão da tolerância aos opiatos e diazepinas ou para o tratamento do vicio das drogas e para a preparação do composto
AU7705694A (en) * 1993-10-04 1995-05-01 Glaxo Wellcome House Substituted urea and isothiourea derivatives as no synthase inhibitors
EP0724570B1 (fr) * 1993-10-21 1999-03-03 G.D. Searle & Co. Derives amidino utiles en tant qu'inhibiteurs de la synthase de l'oxyde nitrique
EP0759027B1 (fr) * 1994-05-07 1999-08-04 Astra Aktiebolag Derives amidine bicycliques comme inhibiteurs de la synthetase de l'oxyde nitrique
BR9509297A (pt) * 1995-08-10 1998-07-07 Astra Ab Composto composição farmacêutica utilização de um composto e processos de tratamento ou prolifaxia de uma doença ou condição na qual a síntese ou suprasintese da sintetase de óxido nitrico forma uma parte contribuinte e desordens neurodegenerativas ou de enxaqueca ou de prevenção e reversão da tolerância a opiatos e diazepinas ou de tratamento do vicio em tóxicos e de preparação de um composto

Also Published As

Publication number Publication date
WO1998050380A1 (fr) 1998-11-12
JP2001523263A (ja) 2001-11-20
NO995404L (no) 2000-01-05
MXPA99009874A (es) 2004-09-30
BR9808725A (pt) 2000-07-11
IS5237A (is) 1999-11-01
CA2287999A1 (fr) 1998-11-12
DE69802923T2 (de) 2002-07-04
EP0983266B1 (fr) 2001-12-12
CN1255130A (zh) 2000-05-31
US6166030A (en) 2000-12-26
AU734394B2 (en) 2001-06-14
DE69802923D1 (de) 2002-01-24
NZ500676A (en) 2001-05-25
ID23156A (id) 2000-03-23
AU7460098A (en) 1998-11-27
TR199902719T2 (xx) 2000-02-21
PL336854A1 (en) 2000-07-17
ZA983740B (en) 1999-02-19
HUP0003766A3 (en) 2001-09-28
KR20010012227A (ko) 2001-02-15
AR012602A1 (es) 2000-11-08
PT983266E (pt) 2002-05-31
SE9701682D0 (sv) 1997-05-05
NO995404D0 (no) 1999-11-04
ES2168757T3 (es) 2002-06-16
EE9900475A (et) 2000-06-15
EP0983266A1 (fr) 2000-03-08
SK140699A3 (en) 2000-06-12
DK0983266T3 (da) 2002-03-11
ATE210661T1 (de) 2001-12-15
HUP0003766A2 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
GB9714102D0 (en) Compounds
GB9715584D0 (en) Compounds
GB9710569D0 (en) Compounds
GB9708694D0 (en) Compounds
GB9708805D0 (en) Compounds
GB9709303D0 (en) Compounds
IL132677A0 (en) Compounds
EP0999205A4 (fr) Composes d'aminocycloalcane
GB9712849D0 (en) Compounds
GB9704522D0 (en) Compounds
GB9702978D0 (en) Compounds
GB9704652D0 (en) Compounds
GB9702607D0 (en) Compounds
GB9704648D0 (en) Compounds
GB9704581D0 (en) Compounds
GB9705189D0 (en) Compounds
GB9708072D0 (en) Compounds
GB9704580D0 (en) Compounds
GB9704579D0 (en) Compounds
GB9704551D0 (en) Compounds
GB9704523D0 (en) Compounds
GB9705194D0 (en) Compounds
GB9726849D0 (en) Compounds
GB9704520D0 (en) Compounds
GB9704490D0 (en) Compounds